OVARIAN PLATELET-RICH PLASMA TREATMENTS MAY REINSTATE OVULATION IN PERIMENOPAUSAL WOMEN AND SIGNIFICANTLY DECREASES SERUM FSH

Abstract

To evaluate perimenopausal women with severely diminished ovarian reserve and anovulation coupled with low AMH and elevated FSH who desire pregnancy using their own oocytes. Autologous platelet-rich plasma (PRP) is a novel medical treatment employed to improve the function and health of different tissues within the body by enhancing the healing and anti-aging process. It has been used in other fields such as orthopedics, cardiothoracic surgery, and dermatology. In this preliminary study, our objective is to measure the effect of Ovarian PRP treatments on the ovulation, oocyte yield, and embryo yield of patients who are historically anovulatory. Ultimately, we want to determine whether Ovarian PRP treatments can reinstate ovulation in anovulatory patients.